Immutep Limited (IMMP)
NASDAQ: IMMP
· Real-Time Price · USD
1.86
-0.02 (-1.06%)
At close: Oct 03, 2025, 3:59 PM
1.90
2.15%
After-hours: Oct 03, 2025, 07:19 PM EDT
-1.06% (1D)
| Bid | 1.77 |
| Market Cap | 273.02M |
| Revenue (ttm) | 5.04M |
| Net Income (ttm) | -61.43M |
| EPS (ttm) | -0.28 |
| PE Ratio (ttm) | -6.64 |
| Forward PE | -3.24 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.98 |
| Volume | 105,363 |
| Avg. Volume (20D) | 82,571 |
| Open | 1.87 |
| Previous Close | 1.88 |
| Day's Range | 1.85 - 1.90 |
| 52-Week Range | 1.32 - 2.71 |
| Beta | 1.51 |
| Ex-Dividend Date | n/a |
About IMMP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMMP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMMP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+8.2%
Immutep shares are trading higher after the compan...
Unlock content with
Pro Subscription
5 months ago
+45.61%
Immutep shares are trading higher after the company provided updates for cohort B of its Tacti-003 Phase IIb trial.
